PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs) can be modified to function as heterologous tumor directed effector cells that survive longer in vivo than tumor directed T cells without virus specificity, due to chronic stimulation by viral antigens expressed during persistent infec...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nakazawa, Yozo, Huye, Leslie E, Salsman, Vita S, Leen, Ann M, Ahmed, Nabil, Rollins, Lisa, Dotti, Gianpietro, Gottschalk, Stephen M, Wilson, Matthew H, Rooney, Cliona M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2011
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242651/
https://ncbi.nlm.nih.gov/pubmed/21772253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.131
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi